Literature DB >> 17614220

Newborn oto-acoustic emission hearing screening tests: preliminary evidence for a marker of susceptibility to SIDS.

Daniel D Rubens1, Betty R Vohr, Richard Tucker, Courtney A O'Neil, Winnie Chung.   

Abstract

OBJECTIVE: To evaluate the newborn transient evoked otoacoustic emission (TEOAE) hearing screening tests of infants later diagnosed with the sudden infant death syndrome (SIDS). STUDY
DESIGN: In a case-controlled study, the newborn TEOAE hearing screens of 31 infants who subsequently died of SIDS were retrospectively compared to those of 31 newborn infants that survived the first year of life. SIDS cases were individually matched to surviving controls based on gender, term versus preterm age and NICU versus well baby nursery.
RESULTS: The TEOAE screens of SIDS infants demonstrated significantly decreased signal to noise ratios at 2000, 3000, and 4000 Hz (p<0.05) on the right side compared to healthy control infants.
CONCLUSION: Newborns at risk for SIDS are currently indistinguishable from other newborns and are only identified following a later fatal event. A unilateral difference in cochlear function is a unique finding that may offer the opportunity to identify infants at risk of SIDS during the early postnatal period with a simple non invasive hearing screen test. The ability to implement preventative measures well in advance of a potential critical incident would be an important breakthrough.

Entities:  

Mesh:

Year:  2007        PMID: 17614220     DOI: 10.1016/j.earlhumdev.2007.06.001

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  Inner ear insult ablates the arousal response to hypoxia and hypercarbia.

Authors:  T Allen; A J Garcia Iii; J Tang; J M Ramirez; D D Rubens
Journal:  Neuroscience       Date:  2013-09-08       Impact factor: 3.590

2.  Activation of alpha-2 noradrenergic receptors is critical for the generation of fictive eupnea and fictive gasping inspiratory activities in mammals in vitro.

Authors:  Jean-Charles Viemari; Alfredo J Garcia; Atsushi Doi; Jan-Marino Ramirez
Journal:  Eur J Neurosci       Date:  2011-05-25       Impact factor: 3.386

3.  Longitudinal Development of Distortion Product Otoacoustic Emissions in Infants With Normal Hearing.

Authors:  Lisa L Hunter; Chelsea M Blankenship; Douglas H Keefe; M Patrick Feeney; David K Brown; Annie McCune; Denis F Fitzpatrick; Li Lin
Journal:  Ear Hear       Date:  2018 Sep/Oct       Impact factor: 3.570

4.  Ear asymmetries in middle-ear, cochlear, and brainstem responses in human infants.

Authors:  Douglas H Keefe; Michael P Gorga; Walt Jesteadt; Lynette M Smith
Journal:  J Acoust Soc Am       Date:  2008-03       Impact factor: 1.840

Review 5.  The physiological determinants of sudden infant death syndrome.

Authors:  Alfredo J Garcia; Jenna E Koschnitzky; Jan-Marino Ramirez
Journal:  Respir Physiol Neurobiol       Date:  2013-06-02       Impact factor: 1.931

6.  Transient Otoacoustic Emissions and Auditory Brainstem Responses in Low-Risk Cohort of Newborn and One-Month-Old Infants: Assessment of Infant Auditory System Physiology in the Prenatal Alcohol in SIDS and Stillbirth Network Safe Passage Study.

Authors:  Yvonne S Sininger; Carmen G Condon; Howard J Hoffman; Amy J Elliott; Hein J Odendaal; Larry L Burd; Michael M Myers; William P Fifer
Journal:  J Am Acad Audiol       Date:  2018-09       Impact factor: 1.664

7.  Sudden infant death syndrome (SIDS) and the routine otoacoustic emission infant hearing screening test: an epidemiological retrospective case-control study.

Authors:  Peter S Blair; Daniel Rubens; Anna Pease; Diane Mellers; Jenny Ingram; Andrew K Ewer; Marta C Cohen; Peter Sidebotham; Martin Ward Platt; Robert Coombs; Adrian Davis; Amanda Hall; Peter Fleming
Journal:  BMJ Open       Date:  2019-07-18       Impact factor: 2.692

8.  Association between auditory system pathology and sudden infant death syndrome (SIDS): a systematic review.

Authors:  Katrine Dahl; Mads Andersen; Tine Brink Henriksen
Journal:  BMJ Open       Date:  2021-12-15       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.